NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1833303452|ref|NP_001368852|]
View 

aminopeptidase N [Homo sapiens]

Protein Classification

M1 family metallopeptidase( domain architecture ID 10176184)

M1 family metallopeptidase containing an ERAP1-like C-terminal domain with HEAT-like repeats is a zinc-dependent metallopeptidase with an HEXXH motif as part of its active site, similar to aminopeptidase N, a broad specificity aminopeptidase, and glutamyl aminopeptidase, which releases N-terminal glutamate from a peptide

EC:  3.4.11.-
Gene Ontology:  GO:0008237|GO:0008270|GO:0006508
MEROPS:  M1

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
84-545 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


:

Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 624.22  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452  84 SYRVTLRPYLTPndrglYVFKGSSTVRFTCKEATDVIIIHSKKLNYTlsqghRVVLRGVGGSQPPDIDKTElVEPTEYLV 163
Cdd:cd09601     2 HYDLTLTPDLEN-----FTFSGSVTITLEVLEPTDTIVLHAKDLTIT-----SASLTLKGGSGIIEVTVVT-DEETEFLT 70
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 164 VHLKGSLVKDSQYEMDSEFEGELADDLAGFYRSEYM-EGNVRKVVATTQMQAADARKSFPCFDEPAMKAEFNITLIHPKD 242
Cdd:cd09601    71 ITLDETLPPGENYTLSIEFTGKLNDDLRGFYRSSYTdEDGETRYLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKG 150
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 243 LTALSNMLPKgPSTPLPEDpnWNVTEFHTTPKMSTYLLAFIVSEFDYVEKQASNGVLIRIWARPSAIaaGHGDYALNVTG 322
Cdd:cd09601   151 YTALSNMPPV-ESTELEDG--WKTTTFETTPPMSTYLVAFVVGDFEYIESTTKSGVPVRVYARPGKI--EQGDFALEVAP 225
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 323 PILNFFAGHYDTPYPLPKSDQIGLPDFNAGAMENWGLVTYRENSLLFDPLSSSSSNKERVVTVIAHELAHQWFGNLVTIE 402
Cdd:cd09601   226 KILDFYEDYFGIPYPLPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMK 305
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 403 WWNDLWLNEGFASYVEYLGADYAEPTWNLKDLMVLNDVYRVMAVDALASSHPLSTPaseINTPAQISELFDAISYSKGAS 482
Cdd:cd09601   306 WWDDLWLNEGFATYMEYLAVDKLFPEWNMWDQFVVDELQSALELDSLASSHPIEVP---VESPSEISEIFDAISYSKGAS 382
                         410       420       430       440       450       460
                  ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1833303452 483 VLRMLSSFLSEDVFKQGLASYLHTFAYQNTIYLNLWDHLQEAVNNrsiQLPTTVRDIMNRWTL 545
Cdd:cd09601   383 VLRMLENFLGEEVFRKGLRKYLKKHAYGNATTDDLWEALQEASGE---SKPLDVKEIMDSWTL 442
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
619-946 5.52e-104

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


:

Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 326.54  E-value: 5.52e-104
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 619 WVLLNLNVTGYYRVNYDEENWRKIQTQLQrdHSAIPVINRAQIINDAFNLASAHKVPVTLALNNTLFLIEERQYMPWEAA 698
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQLL--SKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAA 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 699 LSSLSYFKLMFDRSEVYGPMKNYLKKQVTPLFIHFRNNTNNWreipENLMDQYSEVNAISTACSNGVPECEEMVSGLFKQ 778
Cdd:pfam11838  79 LSQLSTLRSLLSADPEYEALKAFLRKLLSPLAEKLGWEAPPG----ESHLDRQLRALLLSAACSAGDPECVAEAKKLFDA 154
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 779 WMENPNNNPIHpnLRSTVYCNAIAQGGEEEWDFAWEQFRNATLVNEADKLRAALACSKELWILNRYLSYTLNPDLIRKQD 858
Cdd:pfam11838 155 WLDGDDAIPPD--LRWAVYCAAVANGGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALDSDEVRNQD 232
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 859 ATSTIISITNNVIGQGLVWDFVQSNWKKLFNDYGGGsFSFSNLIQAVTRRFSTEYELQQLEQFKKDNEETGFGsgtRALE 938
Cdd:pfam11838 233 LRAVIAGLASNPAGRDLAWDFVKENWDALVKRLGGG-SSLGRLVKGLTPSFSTEEELDEVEAFFADKDTPGLR---RALA 308

                  ....*...
gi 1833303452 939 QALEKTKA 946
Cdd:pfam11838 309 QALETIRR 316
 
Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
84-545 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 624.22  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452  84 SYRVTLRPYLTPndrglYVFKGSSTVRFTCKEATDVIIIHSKKLNYTlsqghRVVLRGVGGSQPPDIDKTElVEPTEYLV 163
Cdd:cd09601     2 HYDLTLTPDLEN-----FTFSGSVTITLEVLEPTDTIVLHAKDLTIT-----SASLTLKGGSGIIEVTVVT-DEETEFLT 70
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 164 VHLKGSLVKDSQYEMDSEFEGELADDLAGFYRSEYM-EGNVRKVVATTQMQAADARKSFPCFDEPAMKAEFNITLIHPKD 242
Cdd:cd09601    71 ITLDETLPPGENYTLSIEFTGKLNDDLRGFYRSSYTdEDGETRYLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKG 150
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 243 LTALSNMLPKgPSTPLPEDpnWNVTEFHTTPKMSTYLLAFIVSEFDYVEKQASNGVLIRIWARPSAIaaGHGDYALNVTG 322
Cdd:cd09601   151 YTALSNMPPV-ESTELEDG--WKTTTFETTPPMSTYLVAFVVGDFEYIESTTKSGVPVRVYARPGKI--EQGDFALEVAP 225
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 323 PILNFFAGHYDTPYPLPKSDQIGLPDFNAGAMENWGLVTYRENSLLFDPLSSSSSNKERVVTVIAHELAHQWFGNLVTIE 402
Cdd:cd09601   226 KILDFYEDYFGIPYPLPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMK 305
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 403 WWNDLWLNEGFASYVEYLGADYAEPTWNLKDLMVLNDVYRVMAVDALASSHPLSTPaseINTPAQISELFDAISYSKGAS 482
Cdd:cd09601   306 WWDDLWLNEGFATYMEYLAVDKLFPEWNMWDQFVVDELQSALELDSLASSHPIEVP---VESPSEISEIFDAISYSKGAS 382
                         410       420       430       440       450       460
                  ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1833303452 483 VLRMLSSFLSEDVFKQGLASYLHTFAYQNTIYLNLWDHLQEAVNNrsiQLPTTVRDIMNRWTL 545
Cdd:cd09601   383 VLRMLENFLGEEVFRKGLRKYLKKHAYGNATTDDLWEALQEASGE---SKPLDVKEIMDSWTL 442
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
75-683 4.64e-120

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 379.37  E-value: 4.64e-120
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452  75 RLPNTLKPDSYRVTLRpyLTPNDRglyVFKGSSTVRFTCKEA-TDVIIIHSKKLnyTLsqgHRVVLRGVggSQPPDIDKT 153
Cdd:COG0308    10 YRPPGYDVTHYDLDLD--LDPATT---RLSGTATITFTATEApLDSLVLDLKGL--EV---TSVTVDGK--PLDFTRDGE 77
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 154 ELVepteylvVHLKGSLVKDSQYEMDSEFEGELADDLAGFYRSEYMEGNvrKVVATTQMQAADARKSFPCFDEPAMKAEF 233
Cdd:COG0308    78 RLT-------ITLPKPLAPGETFTLEIEYSGKPSNGGEGLYRSGDPPDG--PPYLYTQCEPEGARRWFPCFDHPDDKATF 148
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 234 NITLIHPKDLTALSNMLPKGPStplPEDPNWNVTEFHTTPKMSTYLLAFIVSEFDYVEKQASNGVLIRIWARPSAiaAGH 313
Cdd:COG0308   149 TLTVTVPAGWVAVSNGNLVSET---ELGDGRTTWHWADTQPIPTYLFALAAGDYAVVEDTFASGVPLRVYVRPGL--ADK 223
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 314 GDYALNVTGPILNFFAGHYDTPYPLPKSDQIGLPDFNAGAMENWGLVTYRENsLLFDPLSSSSsNKERVVTVIAHELAHQ 393
Cdd:COG0308   224 AKEAFESTKRMLDFFEELFGVPYPFDKYDQVAVPDFNFGAMENQGLVTFGEK-VLADETATDA-DYERRESVIAHELAHQ 301
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 394 WFGNLVTIEWWNDLWLNEGFASYVEYLGADYAEPTWNLKDLMVLNDVYRVMAVDALASSHPLStpaseINTPAQISELFD 473
Cdd:COG0308   302 WFGNLVTCADWDDLWLNEGFATYMEQLFSEDLYGKDAADRIFVGALRSYAFAEDAGPNAHPIR-----PDDYPEIENFFD 376
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 474 AISYSKGASVLRMLSSFLSEDVFKQGLASYLHTFAYQNTIYLNLWDHLqEAVNNRSiqlpttVRDIMNRWTLQMGFPVIT 553
Cdd:COG0308   377 GIVYEKGALVLHMLRTLLGDEAFRAGLRLYFARHAGGNATTEDFLAAL-EEASGRD------LSAFFDQWLYQAGLPTLE 449
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 554 VDTSTGTLSQEHFlldpdsNVTRPSEFNYVWIVPITSIRDGRQQQDYWLIDVRAQNDLFSTsgNEWVLLnlnvtgyyrVN 633
Cdd:COG0308   450 VEYEYDADGKVTL------TLRQTPPRPHPFHIPLEVGLLGGKLTARTVLLDGEQTELVAK--PDPVLL---------LR 512
                         570       580       590       600       610
                  ....*....|....*....|....*....|....*....|....*....|
gi 1833303452 634 YDEEnwrkIQTQLQRDHsaiPVINRAQIINDAFNLASAHKVPVTLALNNT 683
Cdd:COG0308   513 LDDE----LAFLLAHDS---DPFNRWEALQALWRDGEADYLDALRALADT 555
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
316-543 2.99e-112

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 344.66  E-value: 2.99e-112
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 316 YALNVTGPILNFFAGHYDTPYPLPKSDQIGLPDFNAGAMENWGLVTYRENSLLFDPLSSSSSNKERVVTVIAHELAHQWF 395
Cdd:pfam01433   1 YALEITVKLLEFYEDYFNIPYPLPKYDLVALPDFSAGAMENWGLITYRETLLLYDPGNSSTSDKQRVASVIAHELAHQWF 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 396 GNLVTIEWWNDLWLNEGFASYVEYLGADYAEPTWNLKDLMVLNDVYRVMAVDALASSHPLStpaSEINTPAQISELFDAI 475
Cdd:pfam01433  81 GNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIWEQFLLDEVQNAMARDALDSSHPIT---QNVNDPSEIDDIFDAI 157
                         170       180       190       200       210       220
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1833303452 476 SYSKGASVLRMLSSFLSEDVFKQGLASYLHTFAYQNTIYLNLWDHLQEAVNnrsiqlPTTVRDIMNRW 543
Cdd:pfam01433 158 PYEKGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDALSEASG------PLDVDSFMDTW 219
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
619-946 5.52e-104

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 326.54  E-value: 5.52e-104
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 619 WVLLNLNVTGYYRVNYDEENWRKIQTQLQrdHSAIPVINRAQIINDAFNLASAHKVPVTLALNNTLFLIEERQYMPWEAA 698
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQLL--SKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAA 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 699 LSSLSYFKLMFDRSEVYGPMKNYLKKQVTPLFIHFRNNTNNWreipENLMDQYSEVNAISTACSNGVPECEEMVSGLFKQ 778
Cdd:pfam11838  79 LSQLSTLRSLLSADPEYEALKAFLRKLLSPLAEKLGWEAPPG----ESHLDRQLRALLLSAACSAGDPECVAEAKKLFDA 154
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 779 WMENPNNNPIHpnLRSTVYCNAIAQGGEEEWDFAWEQFRNATLVNEADKLRAALACSKELWILNRYLSYTLNPDLIRKQD 858
Cdd:pfam11838 155 WLDGDDAIPPD--LRWAVYCAAVANGGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALDSDEVRNQD 232
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 859 ATSTIISITNNVIGQGLVWDFVQSNWKKLFNDYGGGsFSFSNLIQAVTRRFSTEYELQQLEQFKKDNEETGFGsgtRALE 938
Cdd:pfam11838 233 LRAVIAGLASNPAGRDLAWDFVKENWDALVKRLGGG-SSLGRLVKGLTPSFSTEEELDEVEAFFADKDTPGLR---RALA 308

                  ....*...
gi 1833303452 939 QALEKTKA 946
Cdd:pfam11838 309 QALETIRR 316
pepN_strep_liv TIGR02412
aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the ...
205-526 3.11e-76

aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the zinc metallopeptidase family M1 (pfam01433), with a single member characterized in Streptomyces lividans 66 and designated aminopeptidase N. The spectrum of activity may differ somewhat from the aminopeptidase N clade of E. coli and most other Proteobacteria, well separated phylogenetically within the M1 family. The M1 family also includes leukotriene A-4 hydrolase/aminopeptidase (with a bifunctional active site).


Pssm-ID: 274121 [Multi-domain]  Cd Length: 831  Bit Score: 267.04  E-value: 3.11e-76
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 205 KVVATTQMQAADARKSFPCFDEPAMKAEFNITLIHPKDLTALSNmlpkGPSTPLPEDPNWNVTEFHTTPKMSTYLLAFIV 284
Cdd:TIGR02412 117 EVYLYTQFEPADARRVFAVFDQPDLKANFKFSVKAPEDWTVISN----SRETDVTPEPADRRWEFPETPKLSTYLTAVAA 192
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 285 SEFDYVEKQaSNGVLIRIWARPSAIAAGHGDYALNVTGPILNFFAGHYDTPYPLPKSDQIGLPDFNAGAMENWGLVTYRE 364
Cdd:TIGR02412 193 GPYHSVQDE-SRSYPLGIYARRSLAQYLDADAIFTITRQGLAFFHRKFGYPYPFKKYDQIFVPEFNAGAMENAGCVTFAE 271
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 365 NSLLFDPLSSSSsnKERVVTVIAHELAHQWFGNLVTIEWWNDLWLNEGFASYVEYLGADYAEPTWNLKDLMVLNDVYRVM 444
Cdd:TIGR02412 272 NFLHRAEATRAE--KENRAGVILHEMAHMWFGDLVTMRWWNDLWLNESFAEYMGTLASAEATEYTDAWTTFAAQGKQWAY 349
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 445 AVDALASSHPLSTPASEINTPAQIselFDAISYSKGASVLRMLSSFLSEDVFKQGLASYLHTFAYQNTIYLNLWDHLQEA 524
Cdd:TIGR02412 350 EADQLPTTHPIVADVADLADALSN---FDGITYAKGASVLKQLVAWVGEEAFFAGVNAYFKRHAFGNATLDDLIDSLAKA 426

                  ..
gi 1833303452 525 VN 526
Cdd:TIGR02412 427 SG 428
pepN PRK14015
aminopeptidase N; Provisional
348-507 4.33e-09

aminopeptidase N; Provisional


Pssm-ID: 237585 [Multi-domain]  Cd Length: 875  Bit Score: 60.53  E-value: 4.33e-09
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 348 DFNAGAMENWGLVTYreNS--LLFDPLSSSSSNKERVVTVIAHELAHQWFGNLVTIEWWNDLWLNEG--------FASyv 417
Cdd:PRK14015  262 DFNMGAMENKGLNIF--NSkyVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEGltvfrdqeFSA-- 337
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 418 eylgadyaeptwnlkDLMV-----LNDVyRVM-----AVDALASSHPLStPAS--EIN---TpaqiselfdAISYSKGAS 482
Cdd:PRK14015  338 ---------------DLGSravkrIEDV-RVLraaqfAEDAGPMAHPVR-PDSyiEINnfyT---------ATVYEKGAE 391
                         170       180
                  ....*....|....*....|....*
gi 1833303452 483 VLRMLSSFLSEDVFKQGLASYLHTF 507
Cdd:PRK14015  392 VIRMLHTLLGEEGFRKGMDLYFERH 416
 
Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
84-545 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 624.22  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452  84 SYRVTLRPYLTPndrglYVFKGSSTVRFTCKEATDVIIIHSKKLNYTlsqghRVVLRGVGGSQPPDIDKTElVEPTEYLV 163
Cdd:cd09601     2 HYDLTLTPDLEN-----FTFSGSVTITLEVLEPTDTIVLHAKDLTIT-----SASLTLKGGSGIIEVTVVT-DEETEFLT 70
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 164 VHLKGSLVKDSQYEMDSEFEGELADDLAGFYRSEYM-EGNVRKVVATTQMQAADARKSFPCFDEPAMKAEFNITLIHPKD 242
Cdd:cd09601    71 ITLDETLPPGENYTLSIEFTGKLNDDLRGFYRSSYTdEDGETRYLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKG 150
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 243 LTALSNMLPKgPSTPLPEDpnWNVTEFHTTPKMSTYLLAFIVSEFDYVEKQASNGVLIRIWARPSAIaaGHGDYALNVTG 322
Cdd:cd09601   151 YTALSNMPPV-ESTELEDG--WKTTTFETTPPMSTYLVAFVVGDFEYIESTTKSGVPVRVYARPGKI--EQGDFALEVAP 225
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 323 PILNFFAGHYDTPYPLPKSDQIGLPDFNAGAMENWGLVTYRENSLLFDPLSSSSSNKERVVTVIAHELAHQWFGNLVTIE 402
Cdd:cd09601   226 KILDFYEDYFGIPYPLPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMK 305
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 403 WWNDLWLNEGFASYVEYLGADYAEPTWNLKDLMVLNDVYRVMAVDALASSHPLSTPaseINTPAQISELFDAISYSKGAS 482
Cdd:cd09601   306 WWDDLWLNEGFATYMEYLAVDKLFPEWNMWDQFVVDELQSALELDSLASSHPIEVP---VESPSEISEIFDAISYSKGAS 382
                         410       420       430       440       450       460
                  ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1833303452 483 VLRMLSSFLSEDVFKQGLASYLHTFAYQNTIYLNLWDHLQEAVNNrsiQLPTTVRDIMNRWTL 545
Cdd:cd09601   383 VLRMLENFLGEEVFRKGLRKYLKKHAYGNATTDDLWEALQEASGE---SKPLDVKEIMDSWTL 442
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
75-683 4.64e-120

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 379.37  E-value: 4.64e-120
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452  75 RLPNTLKPDSYRVTLRpyLTPNDRglyVFKGSSTVRFTCKEA-TDVIIIHSKKLnyTLsqgHRVVLRGVggSQPPDIDKT 153
Cdd:COG0308    10 YRPPGYDVTHYDLDLD--LDPATT---RLSGTATITFTATEApLDSLVLDLKGL--EV---TSVTVDGK--PLDFTRDGE 77
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 154 ELVepteylvVHLKGSLVKDSQYEMDSEFEGELADDLAGFYRSEYMEGNvrKVVATTQMQAADARKSFPCFDEPAMKAEF 233
Cdd:COG0308    78 RLT-------ITLPKPLAPGETFTLEIEYSGKPSNGGEGLYRSGDPPDG--PPYLYTQCEPEGARRWFPCFDHPDDKATF 148
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 234 NITLIHPKDLTALSNMLPKGPStplPEDPNWNVTEFHTTPKMSTYLLAFIVSEFDYVEKQASNGVLIRIWARPSAiaAGH 313
Cdd:COG0308   149 TLTVTVPAGWVAVSNGNLVSET---ELGDGRTTWHWADTQPIPTYLFALAAGDYAVVEDTFASGVPLRVYVRPGL--ADK 223
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 314 GDYALNVTGPILNFFAGHYDTPYPLPKSDQIGLPDFNAGAMENWGLVTYRENsLLFDPLSSSSsNKERVVTVIAHELAHQ 393
Cdd:COG0308   224 AKEAFESTKRMLDFFEELFGVPYPFDKYDQVAVPDFNFGAMENQGLVTFGEK-VLADETATDA-DYERRESVIAHELAHQ 301
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 394 WFGNLVTIEWWNDLWLNEGFASYVEYLGADYAEPTWNLKDLMVLNDVYRVMAVDALASSHPLStpaseINTPAQISELFD 473
Cdd:COG0308   302 WFGNLVTCADWDDLWLNEGFATYMEQLFSEDLYGKDAADRIFVGALRSYAFAEDAGPNAHPIR-----PDDYPEIENFFD 376
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 474 AISYSKGASVLRMLSSFLSEDVFKQGLASYLHTFAYQNTIYLNLWDHLqEAVNNRSiqlpttVRDIMNRWTLQMGFPVIT 553
Cdd:COG0308   377 GIVYEKGALVLHMLRTLLGDEAFRAGLRLYFARHAGGNATTEDFLAAL-EEASGRD------LSAFFDQWLYQAGLPTLE 449
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 554 VDTSTGTLSQEHFlldpdsNVTRPSEFNYVWIVPITSIRDGRQQQDYWLIDVRAQNDLFSTsgNEWVLLnlnvtgyyrVN 633
Cdd:COG0308   450 VEYEYDADGKVTL------TLRQTPPRPHPFHIPLEVGLLGGKLTARTVLLDGEQTELVAK--PDPVLL---------LR 512
                         570       580       590       600       610
                  ....*....|....*....|....*....|....*....|....*....|
gi 1833303452 634 YDEEnwrkIQTQLQRDHsaiPVINRAQIINDAFNLASAHKVPVTLALNNT 683
Cdd:COG0308   513 LDDE----LAFLLAHDS---DPFNRWEALQALWRDGEADYLDALRALADT 555
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
316-543 2.99e-112

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 344.66  E-value: 2.99e-112
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 316 YALNVTGPILNFFAGHYDTPYPLPKSDQIGLPDFNAGAMENWGLVTYRENSLLFDPLSSSSSNKERVVTVIAHELAHQWF 395
Cdd:pfam01433   1 YALEITVKLLEFYEDYFNIPYPLPKYDLVALPDFSAGAMENWGLITYRETLLLYDPGNSSTSDKQRVASVIAHELAHQWF 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 396 GNLVTIEWWNDLWLNEGFASYVEYLGADYAEPTWNLKDLMVLNDVYRVMAVDALASSHPLStpaSEINTPAQISELFDAI 475
Cdd:pfam01433  81 GNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIWEQFLLDEVQNAMARDALDSSHPIT---QNVNDPSEIDDIFDAI 157
                         170       180       190       200       210       220
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1833303452 476 SYSKGASVLRMLSSFLSEDVFKQGLASYLHTFAYQNTIYLNLWDHLQEAVNnrsiqlPTTVRDIMNRW 543
Cdd:pfam01433 158 PYEKGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDALSEASG------PLDVDSFMDTW 219
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
619-946 5.52e-104

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 326.54  E-value: 5.52e-104
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 619 WVLLNLNVTGYYRVNYDEENWRKIQTQLQrdHSAIPVINRAQIINDAFNLASAHKVPVTLALNNTLFLIEERQYMPWEAA 698
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQLL--SKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAA 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 699 LSSLSYFKLMFDRSEVYGPMKNYLKKQVTPLFIHFRNNTNNWreipENLMDQYSEVNAISTACSNGVPECEEMVSGLFKQ 778
Cdd:pfam11838  79 LSQLSTLRSLLSADPEYEALKAFLRKLLSPLAEKLGWEAPPG----ESHLDRQLRALLLSAACSAGDPECVAEAKKLFDA 154
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 779 WMENPNNNPIHpnLRSTVYCNAIAQGGEEEWDFAWEQFRNATLVNEADKLRAALACSKELWILNRYLSYTLNPDLIRKQD 858
Cdd:pfam11838 155 WLDGDDAIPPD--LRWAVYCAAVANGGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALDSDEVRNQD 232
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 859 ATSTIISITNNVIGQGLVWDFVQSNWKKLFNDYGGGsFSFSNLIQAVTRRFSTEYELQQLEQFKKDNEETGFGsgtRALE 938
Cdd:pfam11838 233 LRAVIAGLASNPAGRDLAWDFVKENWDALVKRLGGG-SSLGRLVKGLTPSFSTEEELDEVEAFFADKDTPGLR---RALA 308

                  ....*...
gi 1833303452 939 QALEKTKA 946
Cdd:pfam11838 309 QALETIRR 316
M1_APN cd09602
Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the ...
79-524 3.16e-95

Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the catalytic domain of bacterial and eukaryotic aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341065 [Multi-domain]  Cd Length: 440  Bit Score: 307.90  E-value: 3.16e-95
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452  79 TLKPDSYRVTLRpyLTPNDRglyVFKGSSTVRFTCKEAT-DVII------IHS-----KKLNYTLSQGHRVVLrgvggsq 146
Cdd:cd09602    12 LISVVSYDLDLD--LTEGAE---TFRGTVTIRFTLREPGaSLFLdfrggeVKSvtlngRPLDPSAFDGERITL------- 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 147 pPDIDKTELVEpteyLVVhlkgslvkdsqyemdsEFEGELADDLAGFYRSEYMEGNvrKVVATTQMQAADARKSFPCFDE 226
Cdd:cd09602    80 -PGLLKAGENT----VVV----------------EFTAPYSSDGEGLHRFVDPADG--ETYLYTLFEPDDARRVFPCFDQ 136
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 227 PAMKAEFNITLIHPKDLTALSNmlpkGPSTPLPEDPNWNVTEFHTTPKMSTYLLAFIVSEFDYVEKQAsNGVLIRIWARP 306
Cdd:cd09602   137 PDLKATFTLTVTAPADWTVISN----GPETSTEEAGGRKRWRFAETPPLSTYLFAFVAGPYHRVEDEH-DGIPLGLYCRE 211
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 307 SAIA-AGHGDYALNVTGPILNFFAGHYDTPYPLPKSDQIGLPDFNAGAMENWGLVTYRENSLLFDPlsSSSSNKERVVTV 385
Cdd:cd09602   212 SLAEyERDADEIFEVTKQGLDFYEDYFGIPYPFGKYDQVFVPEFNFGAMENPGAVTFRESYLFREE--PTRAQRLRRANT 289
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 386 IAHELAHQWFGNLVTIEWWNDLWLNEGFASYVEYLGADYAEPTWNLKDLMVLNDVYRVMAVDALASSHPLSTPASEINTP 465
Cdd:cd09602   290 ILHEMAHMWFGDLVTMKWWDDLWLNESFADFMAAKALAEATPFTDAWLTFLLRRKPWAYRADQLPTTHPIAQDVPDLEAA 369
                         410       420       430       440       450
                  ....*....|....*....|....*....|....*....|....*....|....*....
gi 1833303452 466 AQIselFDAISYSKGASVLRMLSSFLSEDVFKQGLASYLHTFAYQNTIYLNLWDHLQEA 524
Cdd:cd09602   370 GSN---FDGITYAKGASVLKQLVALVGEEAFRAGLREYFKKHAYGNATLDDLIAALDEA 425
M1 cd09595
Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 ...
103-523 1.02e-89

Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 hydrolase; The model represents the catalytic domains of M1 peptidase family members including aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). All peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile upon activation during catalysis. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. APN expression is dysregulated in many inflammatory diseases and is enhanced in numerous tumor cells, making it a lead target in the development of anti-cancer and anti-inflammatory drugs. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase in LTA4H is as yet unknown, while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals.


Pssm-ID: 341058 [Multi-domain]  Cd Length: 413  Bit Score: 292.43  E-value: 1.02e-89
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 103 FKGSSTVRFTCKEATDVIIIHSKKLNYtlsqgHRVVLRGvggsqppdiDKTELVEPTEYL--VVHLKGSLVKDSQYEMDS 180
Cdd:cd09595    16 LNGTETLTVDASQVGRELVLDLVGLTI-----HSVSVNG---------AAVDFGEREHYDgeKLTIPGPKPPGQTFTVRI 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 181 EFEGELADDLAGFYRseyMEGNVR-KVVATTQMQAADARKSFPCFDEPAMKAEFNITLIHPK-DLTALSNMLPKGPSTPl 258
Cdd:cd09595    82 SFEAKPSKNLLGWLW---EQTAGKeKPYLFTQFEATHARRIFPCIDHPAVKATFTVTITTPKkDLLASNGALVGEETGA- 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 259 pedPNWNVTEFHTTPKMSTYLLAFIVS--EFDYVEKQASNGVLIRIWARPSAIAAGhgDYALNVTGPILNFFAGHYDTPY 336
Cdd:cd09595   158 ---NGRKTYRFEDTPPIPTYLVAVVVGdlEFKYVTVKSQPRVGLSVYSEPLQVDQA--QYAFDATRAALAWFEDYFGGPY 232
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 337 PLPKSDQIGLPDFNAGAMENWGLVTYRENSLLFDPLSSSSsnKERVVTVIAHELAHQWFGNLVTIEWWNDLWLNEGFASY 416
Cdd:cd09595   233 PLPKYDLLAVPDFNSGAMENPGLITFRTTYLLRSKVTDTG--ARSIENVIAHELAHQWFGNLVTMRWWNDLWLNEGFAVY 310
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 417 VEYLGADYAEPTWnLKDLMVLNDVYRVMAVDALASSHPLSTPaseINTPAQISELFDAISYSKGASVLRMLSSFLSEDVF 496
Cdd:cd09595   311 YENRIMDATFGTS-SRHLDQLSGSSDLNTEQLLEDSSPTSTP---VRSPADPDVAYDGVTYAKGALVLRMLEELVGEEAF 386
                         410       420
                  ....*....|....*....|....*..
gi 1833303452 497 KQGLASYLHTFAYQNTIYLNLWDHLQE 523
Cdd:cd09595   387 DKGVQAYFNRHKFKNATTDDFIDALEE 413
pepN_strep_liv TIGR02412
aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the ...
205-526 3.11e-76

aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the zinc metallopeptidase family M1 (pfam01433), with a single member characterized in Streptomyces lividans 66 and designated aminopeptidase N. The spectrum of activity may differ somewhat from the aminopeptidase N clade of E. coli and most other Proteobacteria, well separated phylogenetically within the M1 family. The M1 family also includes leukotriene A-4 hydrolase/aminopeptidase (with a bifunctional active site).


Pssm-ID: 274121 [Multi-domain]  Cd Length: 831  Bit Score: 267.04  E-value: 3.11e-76
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 205 KVVATTQMQAADARKSFPCFDEPAMKAEFNITLIHPKDLTALSNmlpkGPSTPLPEDPNWNVTEFHTTPKMSTYLLAFIV 284
Cdd:TIGR02412 117 EVYLYTQFEPADARRVFAVFDQPDLKANFKFSVKAPEDWTVISN----SRETDVTPEPADRRWEFPETPKLSTYLTAVAA 192
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 285 SEFDYVEKQaSNGVLIRIWARPSAIAAGHGDYALNVTGPILNFFAGHYDTPYPLPKSDQIGLPDFNAGAMENWGLVTYRE 364
Cdd:TIGR02412 193 GPYHSVQDE-SRSYPLGIYARRSLAQYLDADAIFTITRQGLAFFHRKFGYPYPFKKYDQIFVPEFNAGAMENAGCVTFAE 271
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 365 NSLLFDPLSSSSsnKERVVTVIAHELAHQWFGNLVTIEWWNDLWLNEGFASYVEYLGADYAEPTWNLKDLMVLNDVYRVM 444
Cdd:TIGR02412 272 NFLHRAEATRAE--KENRAGVILHEMAHMWFGDLVTMRWWNDLWLNESFAEYMGTLASAEATEYTDAWTTFAAQGKQWAY 349
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 445 AVDALASSHPLSTPASEINTPAQIselFDAISYSKGASVLRMLSSFLSEDVFKQGLASYLHTFAYQNTIYLNLWDHLQEA 524
Cdd:TIGR02412 350 EADQLPTTHPIVADVADLADALSN---FDGITYAKGASVLKQLVAWVGEEAFFAGVNAYFKRHAFGNATLDDLIDSLAKA 426

                  ..
gi 1833303452 525 VN 526
Cdd:TIGR02412 427 SG 428
Peptidase_M1_N pfam17900
Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from ...
81-279 1.00e-74

Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from the M1 family.


Pssm-ID: 465557 [Multi-domain]  Cd Length: 186  Bit Score: 243.41  E-value: 1.00e-74
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452  81 KPDSYRVTLRPYLTPndrglYVFKGSSTVRFTCKEATDVIIIHSKKLNYtlsqgHRVVLRGVGGSQPPDIDKTELVEPTE 160
Cdd:pfam17900   1 VPEHYDLDLKIDLKN-----FTFSGSVTITLQLNNATNVIVLHASDLTI-----RSISLSDEVTSDGVPADFTEDQKDGE 70
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 161 YLVVHLKGSLVKDSQYEMDSEFEGELADDLAGFYRSEYMEGNVRKVVATTQMQAADARKSFPCFDEPAMKAEFNITLIHP 240
Cdd:pfam17900  71 KLTIVLPETLNQTGPYTLEIEYSGELNDSMTGFYRSTYTDNGEKKVLVTTQFEPTDARSAFPCFDEPSVKATFTISIIHP 150
                         170       180       190
                  ....*....|....*....|....*....|....*....
gi 1833303452 241 KDLTALSNMlPKGPSTPLpeDPNWNVTEFHTTPKMSTYL 279
Cdd:pfam17900 151 KDYTALSNM-PVIASEPL--ENGWVITTFEQTPKMSTYL 186
M1_APN_like cd09603
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly ...
85-529 2.61e-58

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly bacterial and some archaeal M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341066 [Multi-domain]  Cd Length: 410  Bit Score: 205.90  E-value: 2.61e-58
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452  85 YRVTLRpyLTPNDRGLyvfKGSSTVRFTCKEATDVIIIHSKKLnytlsQGHRVVLRGVGGSQPPDIDKTelvepteyLVV 164
Cdd:cd09603     6 YDLDLD--YDPATKSL---SGTATITFRATQDLDSLQLDLVGL-----TVSSVTVDGVPAAFFTHDGDK--------LVI 67
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 165 HLKGSLVKDSQYEMDSEFEGelADDLAGFYRSEYMEGNVRKVVATTQMQAADARKSFPCFDEPAMKAEFNITLIHPKDLT 244
Cdd:cd09603    68 TLPRPLAAGETFTVTVRYSG--KPRPAGYPPGDGGGWEEGDDGVWTAGQPEGASTWFPCNDHPDDKATYDITVTVPAGLT 145
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 245 ALSNMLPKGPSTplpEDPNWNVTEFHTTPKMSTYLLAFIVSEFDYVEKQASNGVLIRIWARPSAIAAGHGDYAlnVTGPI 324
Cdd:cd09603   146 VVSNGRLVSTTT---NGGGTTTWHWKMDYPIATYLVTLAVGRYAVVEDGSGGGIPLRYYVPPGDAAKAKASFA--RTPEM 220
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 325 LNFFAGHYdTPYPLPKSDQIGLPDFNaGAMENWGLVTYRENSLLFDPLSssssnkervVTVIAHELAHQWFGNLVTIEWW 404
Cdd:cd09603   221 LDFFEELF-GPYPFEKYGQVVVPDLG-GGMEHQTATTYGNNFLNGDRGS---------ERLIAHELAHQWFGDSVTCADW 289
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 405 NDLWLNEGFASYVEYLGADYAEPTwnlkdlmvlnDVYRvmavDALASSHPLSTPASEINT-PAQISELFDAISYSKGASV 483
Cdd:cd09603   290 ADIWLNEGFATYAEWLWSEHKGGA----------DAYR----AYLAGQRQDYLNADPGPGrPPDPDDLFDRDVYQKGALV 355
                         410       420       430       440
                  ....*....|....*....|....*....|....*....|....*.
gi 1833303452 484 LRMLSSFLSEDVFKQGLASYLHTFAYQNTIylnlWDHLQEAVNNRS 529
Cdd:cd09603   356 LHMLRNLLGDEAFFAALRAYLARYAHGNVT----TEDFIAAAEEVS 397
M1_LTA4H cd09599
Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents ...
210-510 1.41e-33

Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents the N-terminal catalytic domain of leukotriene A4 hydrolase (LTA4H; E.C. 3.3.2.6) and the close homolog cold-active aminopeptidase (Colwellia psychrerythraea-type peptidase; ColAP), both members of the aminopeptidase M1 family. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase is poorly understood while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals. It accepts a variety of substrates, including some opioid, di- and tripeptides, as well as chromogenic aminoacyl-p-nitroanilide derivatives. The aminopeptidase activity of LTA4H is possibly involved in the processing of peptides related to inflammation and host defense. Kinetic analysis shows that LTA4H hydrolyzes arginyl tripeptides with high efficiency and specificity, indicating its function as an arginyl aminopeptidase. Thermodynamic characterization using different biophysical methods shows that structurally distinct inhibitors of the LTA4H occupy different regions of the binding site; while some (RB202, ARM1 and SC57461A) bind to the hydrophobic hydrolase side, both bestatin and captopril are located at the hydrophilic peptidase side. LTB4H overexpression is associated with different pathological conditions and diseases such as cystic fibrosis, coronary heart disease, sepsis, shock, connective tissue disease, and chronic obstructive pulmonary disease. It is also overexpressed in certain human cancers, and has been identified as a functionally important target for mediating anticancer properties of resveratrol, a well-known red wine polyphenolic compound with cancer chemopreventive activity.


Pssm-ID: 341062 [Multi-domain]  Cd Length: 442  Bit Score: 134.89  E-value: 1.41e-33
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 210 TQMQAADARKSFPCFDEPAMKAEFNITLIHPKDLTALSNMLPKGPstplPEDPNWNVTEFHTTPKMSTYLLAFIVSEFdy 289
Cdd:cd09599   129 TQCQAIHARSLFPCQDTPSVKSTYSATVTVPKGLTALMSALRTGE----KEEAGTGTYTFEQPVPIPSYLIAIAVGDL-- 202
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 290 VEKQASNGVliRIWARPSAIAAGHgdYALNVTGPILNfFAGHYDTPYP--------LPKSdqiglpdFNAGAMENWGL-- 359
Cdd:cd09599   203 ESREIGPRS--GVWAEPSVVDAAA--EEFADTEKFLK-AAEKLYGPYVwgrydllvLPPS-------FPYGGMENPCLtf 270
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 360 VTyrensllfdP--LSSSSSNkervVTVIAHELAHQWFGNLVTIEWWNDLWLNEGFASYVEY--LGADYAEPTWNLKDLM 435
Cdd:cd09599   271 AT---------PtlIAGDRSL----VDVIAHEIAHSWSGNLVTNANWEHFWLNEGFTVYLERriLERLYGEEYRQFEAIL 337
                         250       260       270       280       290       300       310
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1833303452 436 VLNDVyrVMAVDALASSHP---LSTPASEINtPaqiSELFDAISYSKGASVLRMLSSFLSEDVFKQGLASYLHTFAYQ 510
Cdd:cd09599   338 GWKDL--QESIKEFGEDPPytlLVPDLKGVD-P---DDAFSSVPYEKGFQFLYYLEQLGGREVFDPFLRAYFKKFAFQ 409
leuko_A4_hydro TIGR02411
leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive ...
210-510 6.54e-27

leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive subset within the zinc metallopeptidase family M1 (pfam01433). The majority of the members of pfam01433 are aminopeptidases, but the sequences in this family for which the function is known are leukotriene A-4 hydrolase. A dual epoxide hydrolase and aminopeptidase activity at the same active site is indicated. The physiological substrate for aminopeptidase activity is not known.


Pssm-ID: 274120 [Multi-domain]  Cd Length: 602  Bit Score: 117.18  E-value: 6.54e-27
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 210 TQMQAADARKSFPCFDEPAMKAEFNITLIHPkdLTALSNMLPKGPStplPEDPnwNVTEFHTTPKMSTYLLAFIVSEFDy 289
Cdd:TIGR02411 128 SQCQAIHARSLFPCQDTPSVKSTYTAEVESP--LPVLMSGIRDGET---SNDP--GKYLFKQKVPIPAYLIAIASGDLA- 199
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 290 vekQASNGVLIRIWARPSAIAAGHGDYALNVTgpilNFF--AGHYDTPYPLPKSDQIGLPD-FNAGAMENWGLvTYRENS 366
Cdd:TIGR02411 200 ---SAPIGPRSTVYSEPEQLEKCQYEFENDTE----KFIktAEDLIFPYEWGQYDLLVLPPsFPYGGMENPNL-TFATPT 271
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 367 LlfdpLSSSSSNkervVTVIAHELAHQWFGNLVTIEWWNDLWLNEGFASYVE--YLGADYAEPTWNLKDLMVLNDVyrVM 444
Cdd:TIGR02411 272 L----IAGDRSN----VDVIAHELAHSWSGNLVTNCSWEHFWLNEGWTVYLErrIIGRLYGEKTRHFSALIGWGDL--QE 341
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1833303452 445 AVDALASSHPLSTPASEINtPAQISELFDAISYSKGASVLRMLSSFL-SEDVFKQGLASYLHTFAYQ 510
Cdd:TIGR02411 342 SVKTLGETPEFTKLVVDLK-DNDPDDAFSSVPYEKGFNFLFYLEQLLgGPAEFDPFLRHYFKKFAYK 407
M1_APN cd09600
Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the ...
347-507 5.36e-22

Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. It includes bacterial-type alanyl aminopeptidases as well as PfA-M1 aminopeptidase (Plasmodium falciparum-type). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341063 [Multi-domain]  Cd Length: 434  Bit Score: 99.90  E-value: 5.36e-22
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 347 PDFNAGAMENWGLVTYRENSLLFDPLSSSSSNKERVVTVIAHELAHQWFGNLVTIEWWNDLWLNEGFASYVEYL-GADYA 425
Cdd:cd09600   249 DDFNMGAMENKGLNIFNSKYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEGLTVFRDQEfSADMN 328
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 426 EPTwnlkdlmvlndVYRVMAVDALAS----------SHPLStPASEIntpaQISELFDAISYSKGASVLRMLSSFLSEDV 495
Cdd:cd09600   329 SRA-----------VKRIEDVRRLRSaqfpedagpmAHPIR-PDSYI----EINNFYTVTVYEKGAEVIRMLHTLLGEEG 392
                         170
                  ....*....|..
gi 1833303452 496 FKQGLASYLHTF 507
Cdd:cd09600   393 FRKGMDLYFERH 404
pepN_proteo TIGR02414
aminopeptidase N, Escherichia coli type; The M1 family of zinc metallopeptidases contains a ...
121-562 4.12e-21

aminopeptidase N, Escherichia coli type; The M1 family of zinc metallopeptidases contains a number of distinct, well-separated clades of proteins with aminopeptidase activity. Several are designated aminopeptidase N, EC 3.4.11.2, after the Escherichia coli enzyme, suggesting a similar activity profile (see SP|P04825 for a description of catalytic activity). This family consists of all aminopeptidases closely related to E. coli PepN and presumed to have similar (not identical) function. Nearly all are found in Proteobacteria, but members are found also in Cyanobacteria, plants, and apicomplexan parasites. This family differs greatly in sequence from the family of aminopeptidases typified by Streptomyces lividans PepN (TIGR02412), from the membrane bound aminopeptidase N family in animals, etc. [Protein fate, Degradation of proteins, peptides, and glycopeptides]


Pssm-ID: 274122 [Multi-domain]  Cd Length: 863  Bit Score: 99.70  E-value: 4.12e-21
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 121 IIHSKKLNYTLSQGHRVVLRGVGGSQPPDIDKTELV---EPTEYLVVHLKGSLVKDSQYEMDSEF--------------E 183
Cdd:TIGR02414   8 LIEKTHLDFDLHEEETVVRARLTVRRNPDGNGAPLVldgEELKLLSIAIDGKPLAAGDYQLDDETltiasvpesftleiE 87
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 184 GELADD----LAGFYRSEymeGNVrkvvaTTQMQAADARKSFPCFDEPAMKAEFNITLI--HPKDLTALSN-------ML 250
Cdd:TIGR02414  88 TEIHPEentsLEGLYKSG---GNF-----CTQCEAEGFRRITYFPDRPDVMSRYTVTITadKKKYPVLLSNgnkiasgEL 159
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 251 PKGPSTPLPEDPNwnvtefhttPKMStYLLAFIVSEFDYVE----KQASNGVLIRIWARPSAIaaGHGDYALNVTGPILN 326
Cdd:TIGR02414 160 PDGRHWAEWEDPF---------PKPS-YLFALVAGDLDVLEdtftTKSGREVALRVYVEEGNK--DKCDHAMESLKKAMK 227
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 327 FFAGHYDTPYPLPKSDQIGLPDFNAGAMENWGLVTYRENSLLFDPLSSSSSNKERVVTVIAHELAHQWFGNLVTIEWWND 406
Cdd:TIGR02414 228 WDEEVFGLEYDLDIFMIVAVDDFNMGAMENKGLNIFNSKYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQ 307
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 407 LWLNEGFASYVEYL-GADY-AEPTWNLKDLMVLNDVYrvMAVDALASSHPLStPASEIntpaQISELFDAISYSKGASVL 484
Cdd:TIGR02414 308 LSLKEGLTVFRDQEfSADMtSRAVKRIEDVRLLRAHQ--FPEDAGPMAHPVR-PESYV----EINNFYTATVYEKGAEVI 380
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 485 RMLSSFLSEDVFKQGLASYLHTFAYQNTIYLNLWDHLQEAVNNRSIQLpttvrdimNRWTLQMGFPVITV----DTSTGT 560
Cdd:TIGR02414 381 RMLHTLLGEEGFRKGMDLYFSRHDGQAVTCEDFVAAMEDASGRDLNQF--------RRWYSQAGTPVLEVkenyDAAKKT 452

                  ..
gi 1833303452 561 LS 562
Cdd:TIGR02414 453 YT 454
M1_APN_like cd09604
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains ...
265-511 5.24e-21

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains bacterial M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341067 [Multi-domain]  Cd Length: 440  Bit Score: 96.96  E-value: 5.24e-21
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 265 NVTEFhttpkmstyllAFIVSEfDYVEKQAS-NGVLIRIWARPSAIAAGhgDYALNVTGPILNFFAGHYdTPYPLPKSDq 343
Cdd:cd09604   200 NVRDF-----------AWAASP-DFVVDAATvDGVTVNVYYLPENAEAA--ERALEYAKDALEFFSEKF-GPYPYPELD- 263
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 344 IGLPDFNAGAMENWGLVTYRensllfdplSSSSSNKERVVTVIAHELAHQWFGNLVTiewwND----LWLNEGFASYVEY 419
Cdd:cd09604   264 VVQGPFGGGGMEYPGLVFIG---------SRLYDPKRSLEGVVVHEIAHQWFYGIVG----NDerrePWLDEGLATYAES 330
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 420 LGADYAEPTWNLKDLMVLNDVYRVMAvdalASSHPLSTPASEINTpaqiSELFDAISYSKGASVLRMLSSFLSEDVFKQG 499
Cdd:cd09604   331 LYLEEKYGKEAADELLGRRYYRAYAR----GPGGPINLPLDTFPD----GSYYSNAVYSKGALFLEELREELGDEAFDKA 402
                         250
                  ....*....|..
gi 1833303452 500 LASYLHTFAYQN 511
Cdd:cd09604   403 LREYYRRYKFKH 414
pepN PRK14015
aminopeptidase N; Provisional
348-507 4.33e-09

aminopeptidase N; Provisional


Pssm-ID: 237585 [Multi-domain]  Cd Length: 875  Bit Score: 60.53  E-value: 4.33e-09
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 348 DFNAGAMENWGLVTYreNS--LLFDPLSSSSSNKERVVTVIAHELAHQWFGNLVTIEWWNDLWLNEG--------FASyv 417
Cdd:PRK14015  262 DFNMGAMENKGLNIF--NSkyVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEGltvfrdqeFSA-- 337
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1833303452 418 eylgadyaeptwnlkDLMV-----LNDVyRVM-----AVDALASSHPLStPAS--EIN---TpaqiselfdAISYSKGAS 482
Cdd:PRK14015  338 ---------------DLGSravkrIEDV-RVLraaqfAEDAGPMAHPVR-PDSyiEINnfyT---------ATVYEKGAE 391
                         170       180
                  ....*....|....*....|....*
gi 1833303452 483 VLRMLSSFLSEDVFKQGLASYLHTF 507
Cdd:PRK14015  392 VIRMLHTLLGEEGFRKGMDLYFERH 416
GluZincin cd09594
Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, ...
385-420 9.46e-07

Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins); The Gluzincin family (thermolysin-like peptidases or TLPs) includes several zinc-dependent metallopeptidases such as M1, M2, M3, M4, M13, M32, M36 peptidases (MEROPS classification), which contain the HEXXH motif as part of their active site. Peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. The M1 family includes aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity such that the two activities occupy different, but overlapping sites. The M3_like peptidases include the M2_ACE, M3 or neurolysin-like family (subfamilies M3B_PepF and M3A) and M32_Taq peptidases. The M2 peptidase angiotensin converting enzyme (ACE, EC 3.4.15.1) catalyzes the conversion of decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. ACE is a key component of the renin-angiotensin system that regulates blood pressure, thus ACE inhibitors are important for the treatment of hypertension. M3A includes thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (3.4.24.16), and the mitochondrial intermediate peptidase; and M3B includes oligopeptidase F. The M32 family includes eukaryotic enzymes from protozoa Trypanosoma cruzi, a causative agent of Chagas' disease, and from Leishmania major, a parasite that causes leishmaniasis, making these enzymes attractive targets for drug development. The M4 family includes secreted protease thermolysin (EC 3.4.24.27), pseudolysin, aureolysin, and neutral protease as well as bacillolysin (EC 3.4.24.28) that degrade extracellular proteins and peptides for bacterial nutrition, especially prior to sporulation. Thermolysin is widely used as a nonspecific protease to obtain fragments for peptide sequencing as well as in production of the artificial sweetener aspartame. The M13 family includes neprilysin (EC 3.4.24.11) and endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad range of physiological roles due to the greater variation in the S2' subsite allowing substrate specificity and are prime therapeutic targets for selective inhibition. The peptidase M36 fungalysin family includes endopeptidases from pathogenic fungi. Fungalysin hydrolyzes extracellular matrix proteins such as elastin and keratin. Aspergillus fumigatus causes the pulmonary disease aspergillosis by invading the lungs of immuno-compromised animals and secreting fungalysin that possibly breaks down proteinaceous structural barriers.


Pssm-ID: 341057 [Multi-domain]  Cd Length: 105  Bit Score: 48.25  E-value: 9.46e-07
                          10        20        30
                  ....*....|....*....|....*....|....*..
gi 1833303452 385 VIAHELAHQWFGNLVTIEW-WNDLWLNEGFASYVEYL 420
Cdd:cd09594    68 VLAHELTHAFTGQFSNLMYsWSSGWLNEGISDYFGGL 104
M1_like_TAF2 cd09839
TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) ...
385-416 2.84e-04

TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) associated factor 2 (TAF2, TBP-associated factor TAFII150, transcription initiation factor TFIID subunit 2, RNA polymerase II TBP-associated factor subunit B), and has homology to the M1 gluzincin family. TAF2 is part of the TFIID multidomain subunit complex essential for transcription of most protein-encoded genes by RNA polymerase II. TAF2 is known to interact with the initiator element (Inr) found at the transcription start site of many genes, thus possibly playing a key role in promoter binding as well as start-site selection. Image analysis has shown TAF2 to form a complex with TAF1 and TBP, inferring its role in promoter recognition. Peptidases in the M1 family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. TAF2, however, lacks these active site residues.


Pssm-ID: 341074 [Multi-domain]  Cd Length: 531  Bit Score: 44.53  E-value: 2.84e-04
                          10        20        30
                  ....*....|....*....|....*....|..
gi 1833303452 385 VIAHELAHQWFGNLVTIEWWNDLWLNEGFASY 416
Cdd:cd09839   377 KLAHALASQWFGINIIPKTWSDTWLVIGIAGY 408
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH